Should You Forget Chevron and Buy This Uranium Stock Instead?

Cameco's 49% stake in Westinghouse could be worth about $24.5 billion if the reactor maker completes a potential IPO at a valuation exceeding $50 billion. Cameco maintained its 2026 production guidance despite mixed Q2 results, while rising AI-driven data-center electricity demand is expected to support uranium demand for several years. The stock is down more than 4% year to date and below its 52-week high, versus Chevron's 36% year-to-date gain; analysts' average $127 price target implies substantial upside, though uranium-price volatility and Westinghouse IPO execution remain key risks.

Analysis

The investable catalyst is not incremental data-center electricity demand; it is a credible price-discovery event for CCJ’s Westinghouse interest. A headline valuation should not be capitalized dollar-for-dollar into CCJ: the appropriate mark is reduced by IPO execution risk, any parent-level financing or tax leakage, governance restrictions, and a 15-30% holding-company discount. The key diligence item is whether an offering creates cash proceeds, a liquid independently valued stake, or merely a paper mark; those outcomes have materially different implications for CCJ’s buyback capacity and SOTP multiple over 1-3 months.

CCJ remains more levered to long-term contract repricing than to spot uranium, so the near-term earnings read-through depends on realized contract volumes, delivery timing, and production reliability rather than bullish commodity narratives. AI-driven load growth is structurally supportive over 6-18 months, but it cannot tighten uranium balances quickly without reactor life extensions, restarts, or new-build milestones; that creates risk that uranium equities outrun the physical market. A softer U3O8 price, another production shortfall, or delayed utility contracting would compress the premium currently afforded to scarce Western supply.

The non-obvious beneficiary of a successful Westinghouse valuation reset is BWXT, whose nuclear-services multiple could re-rate as investors assign greater value to recurring installed-base engineering and aftermarket revenues rather than treating nuclear exposure as a commodity proxy. Conversely, uranium miners with weaker operating execution may lag even in a constructive uranium tape: the market is likely to discriminate between pounds-in-the-ground and dependable contracted delivery.

Key Decisions for Investors

• Initiate a 3-6 month CCJ / URA relative-value long only on confirmation of a Westinghouse filing, banker mandate, or formal strategic-process disclosure; CCJ has a company-specific SOTP catalyst while URA retains broad uranium-price beta. Exit if the process is deferred or disclosed terms imply no monetization path.
• For event exposure, buy CCJ 6-9 month call spreads rather than outright shares; target a structure with roughly 2:1 upside-to-premium risk. This limits downside if uranium spot weakens before IPO details emerge.
• Pair long BWXT / short URA for a 6-12 month nuclear-services versus commodity-beta expression. The trade is invalidated by a sustained U3O8 rally driven by supply disruption, which would favor miners and likely overpower the services multiple thesis.
• Do not rotate from CVX into CCJ solely on relative year-to-date performance. Require evidence of improving realized uranium pricing, maintained production delivery, or a disclosed Westinghouse transaction; absent those, the apparent valuation gap is not a catalyst.